Psychedelic Drugmaker Definium Surges on Depression Drug Success

Bloomberg Published Updated Economy
Sign in to save

Affected assets and topics

BREAKING

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Bullish Confidence 80% How confidence is read Horizon: Short term Impact: Low

Evidence trail

Evidence
Source Bloomberg
Claim Psychedelic Drugmaker Definium Surges on Depression Drug Success
AI inference Bullish · 80%
Generated 2026-06-22 17:23

AI provenance

Analysed by Free Analysis Rule Based Analysis not AI Methodology v1.0 Generated
Technical identifiers
Provider tag
free-analysis-rule-based-analysis
Analysis version
free-analysis-rule-based-analysis
Article id
98724

Original source

Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders.

Read the full article on Bloomberg

Original article published by Bloomberg on June 22, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage

This model on similar stories

Free Analysis Rule Based Analysis · 37.9% correct across 66 scored calls on indices See the full record